Expression of active Akt protects against tamoxifen-induced apoptosis in MCF-7 Cells

Authors

  • Incheol Shin,

    1. Departments of Cancer Biology, Department of Life Science, Hanyang University, Seoul, Korea
    Search for more papers by this author
  • Carlos L. Arteaga

    1. Departments of Cancer Biology, Medicine, Breast Cancer Research Program, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    Search for more papers by this author

Abstract

We investigated the effect of constitutive active Akt expression on anti-proliferative and apoptotic effect of tamoxifen in MCF-7 human breast cancer cells. Forced expression of AktDD (T308D, S473D) resulted in increased phosphorylation of GSK3β, a physiological substrate of Akt. When estrogen receptor (ER) mediated transcription was determined by luciferase assays, there was more than 2-fold increase in estradiol-dependent transcription in MCF-7 cells overexpressing AktDD (MCF-7 AktDD) compared to vector control cells (MCF-7 vec). MCF-7 AktDD cells showed increased proliferation in a medium containing charcoal stripped serum supplemented with estradiol. When the cell cycle profiles were examined, there was an increase in S-phase and a reduction in G1 phase in MCF-7 AktDD cells as compared to MCF-7 vec cells. Overexpression of AktDD also attenuated tamoxifen-mediated apoptosis. These results suggest that Akt could confer resistance to anti-estrogen mediated cell death and inhibition of proliferation. iubmb Life, 58: 664 - 669, 2006

Ancillary